The trial demonstrated positive results in terms of both lean mass retention and weight loss, but researchers recommend continued clinical development and refinement of the drug combination to better understand the common adverse events observed in the bimagrumab groups, such as mild-to-moderate acne and muscle spasms
Research was carried out for 4 consecutive years (2006-2009)
This delivery method ensures 100% bioavailability, bypassing the digestive system for maximum absorption
Russell RG, et al
If you are experiencing intolerable side effects, consult with your healthcare provider
[PMC free article] [PubMed] [Google Scholar] Wood 2008 Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al